161 related articles for article (PubMed ID: 38112103)
1. Somatrogon injection for the treatment of pediatric growth hormone deficiency with comparison to other LAGH products.
Velazquez EP; Miller BS; Yuen KCJ
Expert Rev Endocrinol Metab; 2024; 19(1):1-10. PubMed ID: 38112103
[TBL] [Abstract][Full Text] [Related]
2. Spotlight on Lonapegsomatropin Once-Weekly Injection and Its Potential in the Treatment of Growth Hormone Deficiency in Pediatric Patients.
Miller BS; Yuen KCJ
Drug Des Devel Ther; 2022; 16():2055-2066. PubMed ID: 35791404
[TBL] [Abstract][Full Text] [Related]
3. What do we do now that the long-acting growth hormone is here?
Miller BS
Front Endocrinol (Lausanne); 2022; 13():980979. PubMed ID: 36072938
[TBL] [Abstract][Full Text] [Related]
4. Long-acting growth hormone in the treatment of growth hormone deficiency in children: a systematic literature review and network meta-analysis.
Zhu J; Yuan K; Rana S; Jakki SL; Bhat AS; Liang L; Wang C
Sci Rep; 2024 Apr; 14(1):8061. PubMed ID: 38580693
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, safety, quality of life, adherence and cost-effectiveness of long-acting growth hormone replacement therapy compared to daily growth hormone in children with growth hormone deficiency: A systematic review and meta-analysis.
Mameli C; Orso M; Calcaterra V; Wasniewska MG; Aversa T; Granato S; Bruschini P; Guadagni L; d'Angela D; Spandonaro F; Polistena B; Zuccotti G
Pharmacol Res; 2023 Jul; 193():106805. PubMed ID: 37236413
[TBL] [Abstract][Full Text] [Related]
6. An open-label extension of a phase 2 dose-finding study of once-weekly somatrogon vs. once-daily Genotropin in children with short stature due to growth hormone deficiency: results following 5 years of treatment.
Zadik Z; Zelinska N; Iotova V; Skorodok Y; Malievsky O; Mauras N; Valluri SR; Pastrak A; Rosenfeld R
J Pediatr Endocrinol Metab; 2023 Mar; 36(3):261-269. PubMed ID: 36732285
[TBL] [Abstract][Full Text] [Related]
7. Developments in the Management of Growth Hormone Deficiency: Clinical Utility of Somapacitan.
Miller BS; Blair J; Horikawa R; Linglart A; Yuen KCJ
Drug Des Devel Ther; 2024; 18():291-306. PubMed ID: 38333899
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Once-Weekly Somatrogon Compared with Once-Daily Somatropin (Genotropin®) in Japanese Children with Pediatric Growth Hormone Deficiency: Results from a Randomized Phase 3 Study.
Horikawa R; Tanaka T; Hasegawa Y; Yorifuji T; Ng D; Rosenfeld RG; Hoshino Y; Okayama A; Shima D; Gomez R; Pastrak A; Castellanos O
Horm Res Paediatr; 2022; 95(3):275-285. PubMed ID: 35417909
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study.
Deal CL; Steelman J; Vlachopapadopoulou E; Stawerska R; Silverman LA; Phillip M; Kim HS; Ko C; Malievskiy O; Cara JF; Roland CL; Taylor CT; Valluri SR; Wajnrajch MP; Pastrak A; Miller BS
J Clin Endocrinol Metab; 2022 Jun; 107(7):e2717-e2728. PubMed ID: 35405011
[TBL] [Abstract][Full Text] [Related]
10. Comparing treatment with daily and long-acting growth hormone formulations in adults with growth hormone deficiency: Challenging issues, benefits, and risks.
Höybye C
Best Pract Res Clin Endocrinol Metab; 2023 Dec; 37(6):101788. PubMed ID: 37308376
[TBL] [Abstract][Full Text] [Related]
11. Long-Acting Growth Hormone Preparations - Current Status and Future Considerations.
Miller BS; Velazquez E; Yuen KCJ
J Clin Endocrinol Metab; 2020 Jun; 105(6):e2121-33. PubMed ID: 31676901
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life in pre-pubertal children with pediatric growth hormone deficiency: 12-month results from a phase 3 clinical trial of once-weekly somatrogon versus once-daily somatropin.
Loftus J; Quitmann J; Valluri SR
Curr Med Res Opin; 2024 Feb; 40(2):175-184. PubMed ID: 38053515
[TBL] [Abstract][Full Text] [Related]
13. Usefulness and Potential Pitfalls of Long-Acting Growth Hormone Analogs.
Yuen KCJ; Miller BS; Boguszewski CL; Hoffman AR
Front Endocrinol (Lausanne); 2021; 12():637209. PubMed ID: 33716988
[TBL] [Abstract][Full Text] [Related]
14. Physician experience with once-weekly somatrogon versus once-daily rhGH regimen in pediatric patients with growth hormone deficiency: a cross-sectional survey of physicians from the global phase 3 study.
Gomez R; Lamoureux R; Turner-Bowker DM; Loftus J; Maghnie M; Miller BS; Polak M; Yaworsky A
Front Endocrinol (Lausanne); 2023; 14():1254424. PubMed ID: 37955005
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness and cost-utility analysis of somatrogon once-weekly injections vs. daily growth hormone injection for treating paediatric growth hormone deficiency in Ireland.
Rivolo S; Loftus J; Peter B; Fahey M; Kongnakorn T
J Med Econ; 2023; 26(1):963-972. PubMed ID: 37527156
[TBL] [Abstract][Full Text] [Related]
16. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
Yuen KCJ; Biller BMK; Radovick S; Carmichael JD; Jasim S; Pantalone KM; Hoffman AR
Endocr Pract; 2019 Nov; 25(11):1191-1232. PubMed ID: 31760824
[No Abstract] [Full Text] [Related]
17. Cost-effectiveness of somatrogon in the Spanish pediatric population with growth hormone deficiency.
Andreu Crespo MA; Castro-Feijóo L; Labarta-Aizpún JI; Peral C; Barrueta JA; Rubio-Rodríguez D; Rubio-Terres C
Expert Rev Pharmacoecon Outcomes Res; 2023; 23(10):1139-1146. PubMed ID: 37742226
[TBL] [Abstract][Full Text] [Related]
18. Effective growth hormone replacement with once-weekly somapacitan in Japanese children with growth hormone deficiency: Results from REAL4, a phase 3 clinical trial.
Mori J; Ohata Y; Fujisawa Y; Sato Y; Röhrich S; Rasmussen MH; Bang RB; Horikawa R
Clin Endocrinol (Oxf); 2024 Apr; 100(4):389-398. PubMed ID: 38368603
[TBL] [Abstract][Full Text] [Related]
19.
Gomez R; Khadilkar V; Shembalkar J; Chu DM; Ko CW; Wajnrajch MP; Wang R
J Pediatr Endocrinol Metab; 2024 Jun; 37(6):525-531. PubMed ID: 38717038
[TBL] [Abstract][Full Text] [Related]
20. Effective GH Replacement With Once-weekly Somapacitan vs Daily GH in Children with GHD: 3-year Results From REAL 3.
Sävendahl L; Battelino T; Højby Rasmussen M; Brod M; Saenger P; Horikawa R
J Clin Endocrinol Metab; 2022 Apr; 107(5):1357-1367. PubMed ID: 34964458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
